Jill De Simone Praxis Precision Medicines, Inc. (PRAX) insider trading activity

PRAX Quotes by TradingView

Jill De Simone is Director of Praxis Precision Medicines, Inc.. Currently has a direct ownership of 14,500 shares of PRAX, which is worth approximately $599,720. The most recent transaction as insider was on Oct 05, 2023, when has been sold 14,500 shares (Common Stock) at a price of $1.75 per share, resulting in proceeds of $25,375. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.5K
0% 3M change
n/a 12M change
Total Value Held $599,720

Jill DeSimone Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 05 2023
BUY
Open market or private purchase
$25,375 $1.75 p/Share
14,500 Added 50.0%
14,500 Common Stock

Also insider at

ONCT
Oncternal Therapeutics, Inc. Healthcare
KNTE
Kinnate Biopharma Inc. Healthcare
ITOS
iTeos Therapeutics, Inc. Healthcare
JD

Jill De Simone

Director
Boston, MA

Track Institutional and Insider Activities on PRAX

Follow Praxis Precision Medicines, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRAX shares.

Notify only if

Insider Trading

Get notified when an Praxis Precision Medicines, Inc. insider buys or sells PRAX shares.

Notify only if

News

Receive news related to Praxis Precision Medicines, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PRAX